PRL and COVID-19: This study aims to investigate the role of PRL as a biomarker for disease severity in COVID-19 and its potential modulatory effects on the immune response in moderate to severe cases, filling a gap in the current literature, as no prior studies have systematically examined prolactin’s role in the complex immunological mechanisms of COVID-19 or its prognostic utility.